Skip to main content
. Author manuscript; available in PMC: 2014 Dec 17.
Published in final edited form as: Cochrane Database Syst Rev. 2013 Dec 3;12:CD005431. doi: 10.1002/14651858.CD005431.pub3
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Short-term visual acuity from 20/20 to 20/40 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Risk of secondary hemorrhage 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Time to rebleed (days) Other data No numeric data
4 Risk of corneal blood stain 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Risk of optic atrophy 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
6 Adverse effects 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
 6.1 Conjunctival corneal foreign body sensation 1 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 6.2 Transient punctate corneal staining 1 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 6.3 Dizziness, nausea, vomiting 1 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]